Andrew C Faust1, Pearl Rajan, Lyndsay A Sheperd, Carlos A Alvarez, Phyllis McCorstin, Rebecca L Doebele. 1. From the *Department of Pharmacy, Texas Health Resources Presbyterian Hospital of Dallas, Dallas, Texas; †Texas Tech University Health Sciences Center, College of Pharmacy, Dallas, Texas; ‡Department of Pulmonary and Critical Care Medicine, Texas Health Resources Presbyterian Hospital of Dallas, Dallas, Texas; and §Southwest Pulmonary Associates, Dallas, Texas.
Abstract
BACKGROUND: Recent attention to adverse effects of intensive care unit (ICU) sedation has led to the use of strategies that target a "lighter" depth of sedation. Among these strategies are "analgosedation" protocols, which prioritize pain management and preferentially use IV opioids before administration of continuously infused sedatives such as propofol or midazolam. We hypothesized that using an analgosedation protocol would result in a shorter duration of mechanical ventilation than a protocol with greater emphasis on IV sedatives METHODS: : We conducted a retrospective study comparing the duration of mechanical ventilation before and after implementation of an analgosedation protocol in a 24-bed medical ICU. Patients were aged 18 years or older and required mechanical ventilation where a light level of sedation was clinically appropriate. Exclusion criteria included a clinical need for deeper levels of sedation or tracheal intubation confined to the perioperative period. RESULTS: Seventy-nine patients were included in the postimplementation group and 65 in the preimplementation group. After adjustment for baseline covariates, introduction of the 2013 analgosedation protocol was associated with a decreased duration of mechanical ventilation (-26.62 hours; 95% confidence interval, - 44.98 to -8.26, P = 0.005). Patients managed with the analgosedation protocol experienced a lighter level of sedation (median Richmond Agitation-Sedation Scale, -2.57 vs -1.25, P = 0.001) and improved pain management (median Critical-Care Pain Observation Tool score, 2.0 vs 1.5, P = 0.03). The use of continuously infused sedatives was reduced by 54.3% (92.3% vs 38.0%, P < 0.001). CONCLUSIONS: Our findings suggest that implementation of an analgosedation protocol was associated with an overall lighter level of sedation, shorter mean ventilator duration, and a reduced use of continuous infusion sedatives. Further studies are needed to assess the impact of such protocols on ICU delirium.
BACKGROUND: Recent attention to adverse effects of intensive care unit (ICU) sedation has led to the use of strategies that target a "lighter" depth of sedation. Among these strategies are "analgosedation" protocols, which prioritize pain management and preferentially use IV opioids before administration of continuously infused sedatives such as propofol or midazolam. We hypothesized that using an analgosedation protocol would result in a shorter duration of mechanical ventilation than a protocol with greater emphasis on IV sedatives METHODS: : We conducted a retrospective study comparing the duration of mechanical ventilation before and after implementation of an analgosedation protocol in a 24-bed medical ICU. Patients were aged 18 years or older and required mechanical ventilation where a light level of sedation was clinically appropriate. Exclusion criteria included a clinical need for deeper levels of sedation or tracheal intubation confined to the perioperative period. RESULTS: Seventy-nine patients were included in the postimplementation group and 65 in the preimplementation group. After adjustment for baseline covariates, introduction of the 2013 analgosedation protocol was associated with a decreased duration of mechanical ventilation (-26.62 hours; 95% confidence interval, - 44.98 to -8.26, P = 0.005). Patients managed with the analgosedation protocol experienced a lighter level of sedation (median Richmond Agitation-Sedation Scale, -2.57 vs -1.25, P = 0.001) and improved pain management (median Critical-Care Pain Observation Tool score, 2.0 vs 1.5, P = 0.03). The use of continuously infused sedatives was reduced by 54.3% (92.3% vs 38.0%, P < 0.001). CONCLUSIONS: Our findings suggest that implementation of an analgosedation protocol was associated with an overall lighter level of sedation, shorter mean ventilator duration, and a reduced use of continuous infusion sedatives. Further studies are needed to assess the impact of such protocols on ICU delirium.
Authors: Vincent Joly; Philippe Richebe; Bruno Guignard; Dominique Fletcher; Pierre Maurette; Daniel I Sessler; Marcel Chauvin Journal: Anesthesiology Date: 2005-07 Impact factor: 7.892
Authors: Sandeep Devabhakthuni; Michael J Armahizer; Joseph F Dasta; Sandra L Kane-Gill Journal: Ann Pharmacother Date: 2012-04-10 Impact factor: 3.154
Authors: Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Lancet Date: 2008-01-12 Impact factor: 79.321
Authors: Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke Journal: Crit Care Med Date: 2013-01 Impact factor: 7.598
Authors: Sangeeta Mehta; Lisa Burry; Deborah Cook; Dean Fergusson; Marilyn Steinberg; John Granton; Margaret Herridge; Niall Ferguson; John Devlin; Maged Tanios; Peter Dodek; Robert Fowler; Karen Burns; Michael Jacka; Kendiss Olafson; Yoanna Skrobik; Paul Hébert; Elham Sabri; Maureen Meade Journal: JAMA Date: 2012-11-21 Impact factor: 56.272
Authors: Yahya Shehabi; Rinaldo Bellomo; Michael C Reade; Michael Bailey; Frances Bass; Belinda Howe; Colin McArthur; Ian M Seppelt; Steve Webb; Leonie Weisbrodt Journal: Am J Respir Crit Care Med Date: 2012-08-02 Impact factor: 21.405
Authors: Yahya Shehabi; Lucy Chan; Suhaini Kadiman; Anita Alias; Wan Nasrudin Ismail; Mohd Ali T Ismail Tan; Tien Meng Khoo; Saedah Binti Ali; Mat Ariffin Saman; Ahmad Shaltut; Cheng Cheng Tan; Cow Yen Yong; Michael Bailey Journal: Intensive Care Med Date: 2013-01-24 Impact factor: 17.440
Authors: Bruno Adler Maccagnan Pinheiro Besen; Antonio Paulo Nassar Júnior; Fábio Holanda Lacerda; Carla Marchini Dias da Silva; Vanessa Tota de Souza; Eliana Vieira do Nascimento Martins; Ana Tarina Alvarez Lopes; Carlos Eduardo Brandão; Lucas Fernandes de Oliveira Journal: Rev Bras Ter Intensiva Date: 2019 Oct-Dec